rs138390702
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_005751.5(AKAP9):c.9127G>A(p.Ala3043Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000129 in 1,614,112 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_005751.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AKAP9 | NM_005751.5 | c.9127G>A | p.Ala3043Thr | missense_variant | Exon 37 of 50 | ENST00000356239.8 | NP_005742.4 | |
AKAP9 | NM_147185.3 | c.9103G>A | p.Ala3035Thr | missense_variant | Exon 37 of 50 | NP_671714.1 | ||
AKAP9 | NM_001379277.1 | c.3772G>A | p.Ala1258Thr | missense_variant | Exon 16 of 29 | NP_001366206.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000729 AC: 111AN: 152176Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000191 AC: 48AN: 251372Hom.: 0 AF XY: 0.000191 AC XY: 26AN XY: 135848
GnomAD4 exome AF: 0.0000664 AC: 97AN: 1461818Hom.: 0 Cov.: 30 AF XY: 0.0000509 AC XY: 37AN XY: 727212
GnomAD4 genome AF: 0.000729 AC: 111AN: 152294Hom.: 0 Cov.: 32 AF XY: 0.000644 AC XY: 48AN XY: 74488
ClinVar
Submissions by phenotype
not specified Benign:1
Variant summary: AKAP9 c.9127G>A (p.Ala3043Thr) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00019 in 251372 control chromosomes, predominantly at a frequency of 0.0025 within the African or African-American subpopulation in the gnomAD database. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 750 fold of the estimated maximal expected allele frequency for a pathogenic variant in AKAP9 causing Long QT Syndrome phenotype (3.3e-06), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. To our knowledge, no occurrence of c.9127G>A in individuals affected with Long QT Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Both laboratories classified the variant as likely benign. Based on the evidence outlined above, the variant was classified as likely benign. -
AKAP9-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Long QT syndrome Benign:1
- -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at